Cyfuse Biomedical K.K. (TYO:4892)
Japan · Delayed Price · Currency is JPY 634.00
+48.00 (8.19%)
Mar 5, 2026, 3:30 PM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 6.32 billion as of March 5, 2026. Its market cap has increased by 63.87% in one year.
Market Cap
6.32B
Enterprise Value
3.90B
Revenue
230.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
634.00
Market Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 6.32B, a decrease of -51.42%. That is a compound annual growth rate of -19.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 6.32B | 11.39% |
| Dec 30, 2025 | 5.67B | 54.23% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
| Dec 1, 2022 | 13.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 21.16B |
| Pharma Foods International | 18.01B |
| Taiko Pharmaceutical | 14.97B |
| Wakamoto Pharmaceutical | 11.24B |
| SymBio Pharmaceuticals | 10.37B |
| Morishita Jintan | 9.58B |
| Solasia Pharma K.K. | 9.15B |
| WDB coco | 6.61B |